Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/180474
Title: | GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK |
Author: | Aguilar-Recarte, David Barroso Fernández, Emma Gumà i Garcia, Anna Maria Pizarro Delgado, Javier Peña, Lucía Ruart, Maria Palomer Tarridas, Francesc Xavier Wahli, Walter Vázquez Carrera, Manuel |
Keywords: | Trastorns del metabolisme dels lípids Àcids grassos Receptors nuclears (Bioquímica) Glucosa Lipid metabolism disorders Fatty acids Nuclear receptors (Biochemistry) Glucose |
Issue Date: | 16-Jul-2021 |
Publisher: | Elsevier |
Abstract: | Peroxisome proliferator-activated receptor β/ (PPARβ/) activates AMP-activated protein kinase (AMPK) and plays a crucial role in glucose and lipid metabolism. Here, we examined whether the beneficial effects of PPARβ/δ activation depended on growth differentiation factor 15 (GDF15), a stress response cytokine that regulates energy metabolism. Pharmacological PPARβ/δ activation increased GDF15 levels and ameliorated glucose intolerance, fatty acid oxidation, endoplasmic reticulum stress, inflammation and activated AMPK in HFD-fed mice, whereas these effects were abrogated by the injection of a GDF15 neutralizing antibody and in Gdf15-/- mice. The AMPK-p53 pathway was involved in the PPARβ/δ-mediated increase in GDF15, which in turn activated again AMPK. Finally, Gdf15-/- mice showed reduced AMPK activation in skeletal muscle, whereas GDF15 administration resulted in AMPK activation in this organ. Collectively, these data reveal a novel mechanism by which PPARβ/δ activation increases the levels of GDF15 via AMPK and p53, which in turn mediates the metabolic effects of PPARβ/δ by sustaining AMPK activation. Abbreviations: Acadm, acyl-CoA dehydrogenase medium chain; Acox, acyl-CoA oxidase; AMPK, AMP-activated protein kinase; ATF4, activating transcription factor 4; BiP/GRP78, Binding immunoglobulin protein/78-kDa glucose-regulated protein; CC, compound C; Chop, C/EBP homologous protein; Cpt-1, carnitine palmitoyl-transferase 1; eIF2eukaryotic translation initiation factor 2 ER, endoplasmic reticulum; ERK, extracellular signal-regulated kinase; FGF21, fibroblast growth factor 21; GDF15, growth differentiation factor 15; GFRAL, glial-derived neurotrophic factor receptor α-like; HFD, high-fat diet; Pdk4, pyruvate dehydrogenase kinase 4; IRS, insulin receptor substrate; PGC-1PPAR co-activator 1 PPAR peroxisome proliferator-activated receptor; SOCS3, suppressor of cytokine signaling 3; STAT3, signal transducer and activator of transcription 3; Vldlr, very-low density lipoprotein receptor. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.celrep.2021.109501 |
It is part of: | Cell Reports, 2021, vol. 36, num. 6, p. 109501 |
URI: | http://hdl.handle.net/2445/180474 |
Related resource: | https://doi.org/10.1016/j.celrep.2021.109501 |
ISSN: | 2211-1247 |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
713345.pdf | 6.75 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License